REFERENCES
- Coroneo MT, Giralomo N, Wakefield D. The pathogenesis of pterygia. Curr Opin Ophthalmol. 2009;10:282–288.
- Karagece YU, Seckin S. The expression of p53 and COX- 2 in basal cell carcinoma, squamous cell carcinoma and actinic keratosis cases. Turk Patoloji Derg. 2012;28:119–127.
- Tsai YY, Chang CC, Chiang CC, et al. HPV infection and p53 inactivation in pterygium. Mol Vis. 2009;15:1092–1097.
- Bradley JC, Yang W, Bradley RH, et al. The science of pterygia. Br J Ophthalmol. 2010;94:815–820.
- Chui J, Coroneo MT, Tat LT, et al. Ophthalmic pterygium: a stem cell disorder with premalignant features. Am J Pathol. 2011;178:817–827.
- Hirst LW, Axelsen RA, Schwab I. Pterygium and associated ocular surface squamous neoplasia. Arch Ophthalmol. 2009;127:31–32.
- Iikura M, Miyamasu M, Yamaguchi M, et al. Chemokine receptors in human basophils: Inducible expression of functional CXCR4. J Leukoc Biol. 2001;70:113–120.
- Jinquan T, Jacobi HH, Jing C, et al. Chemokine stromal cell-derived factor 1 alpha activates basophils by means of CXCR4. J Allergy Clin Immunol. 2000;106:313–320.
- Sun X, Cheng G, Hao M, et al. CXCL12/CXCR4 /CXCR/ chemokine axis and cancer progression. Cancer Metastasis Rev. 2010;29:709–722.
- Balkwill F. Cancer and the chemokine network. Nat. Rev. Cancer. 2004;4:540–550.
- Dannenberg AJ, Subbaramaiah K. Targeting cyclooxygenase-2 in human neoplasia: rationale and promise. Cancer Cell. 2003;4:431–436.
- Amano H, Hayashi I, Endo H, et al. Host prostaglandin E(2)-EP3 signaling regulates tumor-associated angiogenesis and tumor growth. J Exp Med. 2003;197:221–232.
- Obermajer N, Kalinski P. Key role of the positive feedback between PGE2 and COX2 in the biology of myeloid-derived suppressor cells. Oncoimmunology. 2012;1:1(5):762–764.
- Chiang CC, Cheng YW, Lin CL, et al. Cyclooxygenase 2 expression in pterygium. Mol Vis. 2007;13:635–638.
- Maxia C, Perra MT, Demurtas P, et al. Relationship between the expression of cyclooxygenase-2 and surviving in primary pterygium. Mol Vis. 2009;15:458–463.
- Karahan N, Baspinar S, Ciris M, et al. Cyclooxygenase-2 expression in primary and recurrent pterygium. Indian J Ophthalmol. 2008;56:279–283.
- Adiguzel U, Karabacak T, Sari A, et al. Cyclooxygenase-2 expression in primary and recurrent pterygium. Eur J Ophthalmol. 2007;17:879–884.
- Kim KW, Park SH, Lee SH, et al. Upregulated stromal cell-derived factor 1(SDF-1) expression and its interaction with CXCR4 contribute to the pathogenesis of severe pterygia. Invest Ophthalmol Vis Sci. 2013;54:7198–7206.
- Sivrikoz ON, Uyar B, Dag F, et al. CXCR-4 and COX-2 expression in basal cell carcinomas and well-differentiated squamous cell carcinomas of the skin; their relationship with tumor invasiveness and histological subtype. Turk Patoloji Derg. 2014;31:30–35.
- Obermajer N, Muthuswamy R, Odunsi K, et al. PGE2-induced CXCL12 production and CXCR4 expression controls the accumulation of human MDSCs in ovarian cancer environment. Cancer Res. 2011;71:7463–7470.
- Silva RL, Shen J, Hackett SF, et al. The SDF-1/CXCR4 ligand/receptor pair is an important contributor to several types of ocular neovascularization. FASEB J. 2007;21:3219–3230.
- Shen M, Yuan F, Jin J, et al. The effect of TC14012 on alkali burn-induced corneal neovascularization in mice. Ophthalmic Res. 2014;52:17–24.
- Abu El-Asrar AM, Struyf S, Van Damme J, et al. Circulating fibrocytes contribute to the myofibroblast population in proliferative vitreoretinopathy epiretinal membranes. Br J Ophthalmol. 2008;92:699–704.
- Salcedo R, Zhang X, Young HA, et al. Angiogenic effects of prostaglandin E2 are mediated by up-regulation of CXCR4 on human microvascular endothelial cells. Blood. 2003; 102:1966–1977.
- Park CY, Choi JS, Lee SJ, et al. Cyclooxygenase-2-expressing macrophages in human pterygium co-express vascular endothelial growth factor. Mol Vis. 2011;17:3468–3480.
- Abe R, Donnelly SC, Peng T, et al. Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol. 2001;166:7556–7562.
- Bellini A, Mattoli S. The role of the fibrocyte, a bone marrow-derived mesenchymal progenitor, in reactive and reparative fibroses. Lab Invest. 2007;87:858–870.
- Touhami A, Di Pascuale MA, Kawatika T, et al. Characterisation of myofibroblasts in fibrovascular tissues of primary and recurrent pterygia. Br J Ophthalmol. 2005;89:269–274.
- Xu QY, Yuan YZ, Wang LY, et al. Anti-angiogenesis effect of AMD3100 in oxygen-induced retinopathy mice. [Article in Chinese]. Zhonghua Yan Ke Za Zhi. 2012;48:350–355.